Clinical Policy: Gender-Affirming Procedures
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.MP.95 alerts
Get alerted when Policy CP.MP.95 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity criteria and coding guidance for gender-affirming medical and surgical treatments for members/enrollees when such services are included under the benefit plan.
No material clinical or coverage changes in this revision.
Coverage Criteria for Gender-Affirming Treatments
General eligibility for gender-affirming surgeries
Covered when ALL of the following are met
see section I.A
see section I.B items 1-4
B.5 age-specific requirements
- Adult pathway: Assessment for GAMST by a provider experienced in or qualified to assess clinical aspects of gender dysphoria/incongruence who is licensed and holds at minimum a master's degree (or equivalent further clinical training); documented assessment identifies mental/physical conditions that could affect outcome and includes discussion of reproductive effects and options; member remains stable on gender-affirming hormone regimen (which may include at least 6 months of hormone therapy unless hormone therapy is not desired or is medically contraindicated).
section I.B.5.a
- Adolescent pathway: Demonstrates emotional and cognitive maturity for consent/assent; has reached Tanner stage 2; informed of reproductive effects of GAMST and fertility preservation options discussed in context of pubertal development; completed minimum 12 months of gender-affirming hormone therapy (or longer if required to achieve desired surgical result) unless hormone therapy is not desired or medically contraindicated; assessment performed by a provider qualified for adolescent GAMST (licensed with postgraduate degree or equivalent and relevant expertise).
section I.B.5.b
section I.C
Facial gender-affirming procedures
Covered when ALL of the following are met
section II
Revision procedures
Covered when ALL of the following are met
section III
Primary policy criteria (high-level)
Criteria updated to incorporate WPATH Standards of Care version 8; intersex individuals are not subject to the same criteria.
See revision history and references
Policy note prior to criteria section
Appearance-only exclusion replaces prior cosmetic-procedure list
From revision notes aligning with SOC-8
It is the policy of Arizona Complete Health that procedures performed solely to improve appearance and that are unrelated to an individual’s gender expression are not medically necessary. Such services are considered cosmetic and are excluded from coverage.
Procedures whose only purpose is to enhance or alter appearance and that do not address gender dysphoria or gender incongruence are not medically necessary. Claims for interventions performed solely for appearance improvement and unrelated to gender expression may be denied.
Any procedure described as cosmetic-only and not intended to treat or align physical characteristics with the member’s experienced gender will be considered not medically necessary and is excluded from coverage under this policy.
Revision surgeries requested for purely cosmetic reasons — that is, revisions not intended to correct a complication of a prior gender-affirming procedure and not related to gender expression — are classified as not medically necessary. Revisions that are required to address complications (for example, wound dehiscence, fistula, or chronic pain directly related to the original surgery) remain medically necessary when documentation supports the clinical need.
Coding and Procedure Codes
| 11950 | Subcutaneous injection of filling material (eg, collagen). |
| 11951 | Subcutaneous injection of filling material (eg, collagen). |
| 11952 | Subcutaneous injection of filling material (eg, collagen). |
| 11953 | Subcutaneous injection of filling material (eg, collagen). |
| 11954 | Subcutaneous injection of filling material (eg, collagen). |
| 11960 | Insertion of tissue expander(s) for other than breast, including subsequent expansion. |
| 11970 | Replacement of tissue expander with permanent implant. |
| 14000 | Adjacent tissue transfer or rearrangement, trunk; defect 10 sq cm or less. |
| 14001 | Adjacent tissue transfer or rearrangement, trunk; defect 10.1 sq cm to 30.0 sq cm. |
| 14040 | Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10 sq cm or less. |
| 17380 | Electrolysis epilation, each 30 minutes. |
| 19303 | Mastectomy, simple, complete. |
| 19325 | Breast augmentation with implant. |
| 21120 | Genioplasty; augmentation (autograft, allograft, prosthetic material). |
| 30400 | Rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip. |
| 53410 | Urethroplasty, 1-stage reconstruction of male anterior urethra. |
| 54125 | Amputation of penis; complete. |
| 54400 | Insertion of penile prosthesis; non-inflatable (semi-rigid). |
| 21208 | Augmentation, mandibular body or angle; with bone graft, onlay or interpositional (includes obtaining autograft). |
| 21209 | Osteoplasty, facial bones; augmentation (autograft, allograft, or prosthetic implant). |
| 21210 | Osteoplasty, facial bones; reduction. |
| 21270 | Graft, bone; nasal, maxillary or malar areas (includes obtaining graft). |
| 30400 | Rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip. |
| 30410 | Rhinoplasty, primary; complete, external parts including bony pyramid, lateral and alar cartilages, and/or elevation of nasal tip. |
| 30420 | Rhinoplasty, primary; including major septal repair. |
| 30430 | Rhinoplasty, secondary; minor revision (small amount of nasal tip work). |
| 30435 | Rhinoplasty, secondary; intermediate revision (bony work with osteotomies). |
| 30450 | Rhinoplasty, secondary; major revision (nasal tip work and osteotomies). |
| 31599 | Unlisted procedure, larynx. |
| 31899 | Unlisted procedure, trachea, bronchi. |
| 53410 | Urethroplasty, 1-stage reconstruction of male anterior urethra. |
| 53415 | Urethroplasty, transpubic or perineal, 1-stage, for reconstruction or repair of prostatic or membranous urethra. |
| 53420 | Urethroplasty, 2-stage reconstruction or repair of prostatic or membranous urethra; first stage. |
| 53425 | Urethroplasty, 2-stage reconstruction or repair of prostatic or membranous urethra; second stage. |
| 53430 | Urethroplasty reconstruction female urethra. |
| 53460 | Urethromeatoplasty, with partial excision of distal urethral segment (Richardson type procedure). |
| 58275 | Vaginal hysterectomy, with total or partial vaginectomy. |
| 58285 | Vaginal hysterectomy, radical (Schauta type operation). |
| 58290 | Vaginal hysterectomy, for uterus greater than 250 g. |
| 58291 | Vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s). |
| 58292 | Vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s), with repair of enterocele. |
| 58294 | Vaginal hysterectomy, for uterus greater than 250 g; with repair of enterocele. |
| 58541 | Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less. |
| 58542 | Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(s). |
| 58543 | Laparoscopy, surgical, supracervical hysterectomy, for uterus greater than 250 g. |
| 58544 | Laparoscopy, surgical, supracervical hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s). |
| 58570 | Laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less. |
| 58571 | Laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(s). |
| 58572 | Laparoscopy, surgical, with total hysterectomy for uterus greater than 250 g. |
| 58573 | Laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s). |
| 58661 | Laparoscopy surgical; with removal of adnexal structures (partial or total oophorectomy and/or salpingectomy). |
| 58720 | Salpingo-oophorectomy, complete or partial, unilateral or bilateral (separate procedure). |
| 58940 | Oophorectomy, partial or total, unilateral or bilateral. |
| 58999 | Unlisted procedure, female genital system (nonobstetrical). |
| 64856 | Suture of major peripheral nerve, arm or leg, except sciatic; including transposition. |
| 64892 | Nerve graft (includes obtaining graft), single strand, arm or leg; up to 4 cm length. |
Prior Authorization, Documentation, and Provider Requirements
Prior Authorization: Eligibility Verification
Prior authorization required. Verify member eligibility and that all diagnostic criteria and policy requirements are met before submitting an authorization request.
- Prior authorization required for listed gender-affirming procedures and associated CPT codes.
- Authorization requests must document diagnosis of gender dysphoria/gender incongruence and meet the policy's eligibility criteria.
Prior Authorization Required for Listed CPT Codes
Prior authorization is required for the CPT codes listed in the policy. Include supporting clinical documentation with the authorization request to allow medical necessity determination.
- Submit requests for codes such as 21208, 21209, 21210, 21270, 30400–30435, 53410–53430, 54125, 54400–54417, 54520, 54660, 55175, 55970–55980, 56625, 56800–56810, 57106–57296, 57335, 58150, 58541–58554, 58661, 58720, 58940, 64856, 64892, 64896, 67900, and other listed CPTs in the policy.
- If a code is not listed, include operative reports and rationale to support medical necessity.
Hormone Therapy Prerequisite
Many procedures require a period of gender-affirming hormone therapy prior to surgery unless hormone therapy is not desired or is medically contraindicated. Confirm and document hormone therapy status and duration.
- Members ≥18: typically a minimum of 6 months of hormone therapy is required and member should be stable on their hormone regimen, unless hormones are not desired or contraindicated.
- Members <18: typically a minimum of 12 months of hormone therapy is required prior to many procedures (breast augmentation, phalloplasty, metoidioplasty, vaginoplasty, gonadectomy, facial surgery), unless not desired or medically contraindicated.
Prior Treatment Duration Considerations
Duration requirements may be applied with clinical flexibility, particularly for adolescents. Consider case‑by‑case assessment (e.g., mastectomy in adolescents) and document rationale when deviating from standard minimum durations.
- Policy allows case-by-case consideration for the 12-month hormone therapy requirement in adolescents.
- If shorter or longer hormone duration is requested, provide clinical justification and supporting documentation.
Required Clinical Documentation
Provide complete clinical documentation with the prior authorization. At minimum, include one signed written statement from a qualified provider and a documented assessment addressing mental and physical health concerns relevant to gender-affirming care.
- One written signed recommendation for gender-affirming medical and surgical treatment (GAMST) from a provider competent to assess and diagnose gender incongruence is required.
- Document assessment must identify any medical or mental health conditions that could negatively impact outcomes and evidence that such conditions are reasonably well controlled.
- Document discussion of reproductive effects and fertility preservation options prior to initiation of GAMST.
Required Clinical Documentation (High-level)
Documentation must be consistent with WPATH Standards of Care (SOC-8) and include providers who meet the policy's qualifications. Mental health provider characteristics and referral letter requirements must align with policy standards.
- Assessments should be performed by providers experienced or qualified in transgender health and statutorily licensed; for adults this typically includes providers with relevant clinical master's level training or equivalent.
- For minors, documentation must demonstrate emotional/cognitive maturity, Tanner stage ≥2, and meet the policy's informed consent requirements.
- Documentation consistent with WPATH SOC-8 is expected; prior authorization may be denied if documentation is incomplete or does not meet SOC-8-aligned criteria.
Cosmetic Exclusion
Procedures performed solely to improve appearance and unrelated to gender expression are not medically necessary and may be denied. When the requested procedure is primarily cosmetic, clearly document how it is integral to the member's gender-affirming treatment to support medical necessity.
- Cosmetic-only procedures unrelated to gender expression may be denied as not medically necessary.
- Provide clear clinical justification and documentation tying the requested procedure to treatment of gender dysphoria/gender incongruence when applicable.
Background and Context
Gender dysphoria or gender incongruence refers to a marked and sustained incongruence between an individual’s experienced or expressed gender and the sex assigned at birth, which can result in clinically significant distress or impairment. Management is individualized and may include social transition, hormone therapy, psychotherapy, and surgical interventions. The policy criteria have been updated to align with the World Professional Association for Transgender Health Standards of Care (WPATH SOC-8), and assessments and provider qualifications referenced in the policy reflect those standards.
Definitions and Qualified Providers
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.